Are serotonin and noradrenaline reuptake inhibitors effective, tolerable, and safe for adults with fibromyalgia? A cochrane review summary with commentary

Journal of Musculoskeletal Neuronal Interactions

Volumn 18, Issue 4, 2018, Pages 404-406

  Grubišić, Frane ^a  

^a SESTRE MILOSRDNICE UNIVERSITY HOSPITAL   (Croatia)

Author keywords

Cochrane Review Summary; Fibromyalgia; Rehabilitation; Serotonin and Noradrenaline Reuptake Inhibitors

Indexed keywords

CARNITINE; DESVENLAFAXINE; DULOXETINE; MILNACIPRAN; PLACEBO; PREGABALIN; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; VENLAFAXINE;

ADULT; ANXIETY; ARTICLE; DISABILITY; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FATIGUE; FIBROMYALGIA; HUMAN; MEDICAL DECISION MAKING; OUTCOME ASSESSMENT; PAIN; QUALITY OF LIFE; RISK BENEFIT ANALYSIS; SLEEP; SYMPTOM; TREATMENT OUTCOME; BLEEDING; HYPERTENSION;

ADULT; FIBROMYALGIA; HEMORRHAGE; HUMANS; HYPERTENSION; SEROTONIN AND NORADRENALINE REUPTAKE INHIBITORS; SYSTEMATIC REVIEWS AS TOPIC; TREATMENT OUTCOME;

EID: 85058493355     PISSN: 11087161     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (6)

1. Welsch P, Üçeyler N, Klose P, Walitt B, Häuser W. Serotonin and noradrenaline reuptake inhibitors (SNRIs) for fibromyalgia. Cochrane Database Syst Rev 2018;2:CD010292. doi: 10.1002/14651858. CD010292.pub2.
2. Wolfe F, Clauw DJ, Fitzcharles MA, Goldenberg DL, Häuser W, Katz RL, Mease PJ, Russell AS, Russell IJ, Walitt B. 2016 Revisions to the 2010/2011 fibromyalgia diagnostic criteria. Semin Arthritis Rheum 2016;46(3):319-29.
3. Cieza A, Stucki G, Weigl M, Kullmann L, Stoll T, Kamen L, Kostanjsek N, Walsh N. ICF Core Sets for chronic widespread pain. J Rehabil Med 2004;(44):63-8.
4. Oral A, Ilieva EM, Küçükdeveci AA, Varela E, Valero R, Berteanu M, Christodoulou N. Generalised and regional soft tissue pain syndromes. The role of physical and rehabilitation medicine physicians. The European perspective based on the best evidence. A paper by the UEMS-PRM Section Professional Practice Committee. Eur J Phys Rehabil Med 2013;49(4):535-49.
5. Macfarlane GJ, Kronisch C, Dean LE, Atzeni F, Häuser W, Fluß E, Choy E, Kosek E, Amris K, Branco J, Dincer F, Leino-Arjas P, Longley K, McCarthy GM, Makri S, Perrot S, Sarzi-Puttini P, Taylor A, Jones GT. EULAR revised recommendations for the management of fibromyalgia. Ann Rheum Dis 2017;76(2):318-28.
6. WHO. International Classification of Functioning, Disability and Health (ICF). World Health Organization, Geneva, 2001.